Literature DB >> 2868205

IgA antibody to lipid A in alcoholic liver disease.

J P Nolan, M G DeLissio, D S Camara, D M Feind, N C Gagliardi.   

Abstract

To find out whether the increased immunoglobulin A (IgA) levels commonly reported in patients with alcoholic liver disease (ALD) are part of the immune response to gut-derived endotoxin antigen, an enzyme-linked immunoabsorbent assay was used to measure serum levels of antibodies to lipid A (the shared core of various lipopolysaccharides and the biologically active component of endotoxins) in patients with various diseases and in controls. Of 41 patients with ALD, 35 had significantly raised titres of IgA anti-lipid A. Rises of antilipid A were found in the secretory fraction of IgA as well, and titres of IgG antibody were also consistently increased. IgM titres were high in only 7 of 35 ALD patients tested. Patients with other diseases did not show significantly high titres of IgA antibodies to lipid A even though many had rises in total concentration of their serum IgA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868205     DOI: 10.1016/s0140-6736(86)90652-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

Review 1.  Intestinal endotoxins and macrophages as mediators of liver injury.

Authors:  J P Nolan; D S Camara
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

2.  IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease?

Authors:  Alexandr Parlesak; Christian Schäfer; Christiane Bode
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

3.  Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.

Authors:  G R Yeaman; M A Kerr
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

Review 4.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.